Silence Therapeutics (United Kingdom)

Silence Therapeutics (United Kingdom)

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Silence Therapeutics (United Kingdom), United Kingdom, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

63%


Total
Publications

94


Total Open
Publications

59


Total
Citations

2.5K


Open Access
Percentage

63%


Total
Publications

94


Total Open
Publications

59


Total
Citations

2.5K

Wikipedia

Website

download

Breakdown

16% 44% 3% 37%

Publisher Open

16%

Both

44%

Other Platform Open

3%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

16

Hybrid 30%

17

No Guarantees 41%

23

Other Platform Open

Domain 84%

37

Institution 39%

17

Public 9%

4

Other Internet 9%

4

Preprint 5%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
37
Europe PMC
Domain
16
Figshare
Public
14
University College London - UCL Discovery
Institution
4
University of East Anglia - UEA Digital Repository
Institution
3
University of the Basque Country - Communities in ADDI
Institution
2
University of Edinburgh - Edinburgh Research Explorer
Institution
2
University of Bristol - Bristol Research
Institution
2
Spanish National Research Council (CSIC) - DIGITAL.CSIC
Institution
2
Radboud University - Radboud Repository
Institution
2
1 / 3

Data updated 7 October 2024

Share

Share

Share